GNI Group Ltd 2160.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 03/03/21 JST
2,076.00UNCH (UNCH)
52 week range
985.00 - 4,070.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2,076.00
  • 52 Week High4,070.00
  • 52 Week High Date10/06/20
  • 52 Week Low985.00
  • 52 Week Low Date03/13/20
  • Market Cap822.52M
  • Shares Out43.51M
  • 10 Day Average Volume1.04M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change52.31

RATIOS/PROFITABILITY

  • EPS (TTM)17.00
  • P/E (TTM)122.12
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest GNI Group Ltd News

There is no recent news for this security.

Latest 2160.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
GNI Group Ltd. is a Japan-based company engaged in new drug production activities utilizing biotechnologies. The Company is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. It is engaged in research and development of therapeutic agents, including F647 for radiation pneumonia (RP) and idiopathic pulmonary fibrosis (IPF), F351 for...
Ying Luo
Chief Executive Officer
Thomas Eastling
Chief Financial Officer
Address
3F, Nihonbashi-Honcho YS Bldg
2-2-2, Nihonbashi Hon-cho
Chuo-ku, TKY
103-0023
Japan